1. Isolation of bioactive phytochemicals from Crinum asiaticum L. along with their cytotoxic and TRAIL-resistance abrogating prospect assessment
- Author
-
Sharmin Ahmed Rakhi, Yasumasa Hara, Md. Saiful Islam, Teruhisa Manome, Safaet Alam, Nazim Uddin Emon, Muhammad Abdullah Al-Mansur, Md. Ruhul Kuddus, Md. Raihan Sarkar, Masami Ishibashi, and Firoj Ahmed
- Subjects
Crinum asiaticum ,TRAIL-Resistance abrogating activity ,Cytotoxicity ,Molecular docking ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Crinum asiaticum L. (Amaryllidaceae) is a perennial bulbous herb, locally utilized for possessing multifaceted pharmacological properties including anticancer, immune-stimulating, analgesic, antiviral, antimalarial, antibacterial and antifungal, in addition to its popularity as an aesthetic plant. Separation of MeOH extract of C. asiaticum leaves yielded three known compounds as cycloneolitsol (1), hippeastrine (2) and β-sitosterol (3). Among these, compounds 1 and 2 were subjected to the cytotoxic assay and found that they induced mild effect against HCT116, Huh7 and DU145 cell lines with the IC50 values from 73.76 to 132.53 μM. When tested for TRAIL-resistance abrogating activity, 1 (100 μM) along with TRAIL (100 ng/mL) showed moderate activity in AGS cells producing 25 % more inhibition than the agent alone. Whereas 2 (20 and 30 μM) in combination with TRAIL (100 ng/mL) exhibited strong activity in abrogating TRAIL-resistance and caused 34 % and 36 % more inhibition in AGS cells, respectively. The in-silico studies of compound 2 revealed high docking hits with the TRAIL-associated anti-apoptotic proteins which give a justification for the regulatory interactions to induce such abrogating activity. It is still recommended to conduct further investigations to understand their exact molecular mechanism.
- Published
- 2024
- Full Text
- View/download PDF